ITPRIPL2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.665200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.225400E-01
Normal-vs-Stage2
4.601800E-01
Normal-vs-Stage3
7.723600E-01
Normal-vs-Stage4
2.660000E-01
Stage1-vs-Stage2
5.197800E-01
Stage1-vs-Stage3
5.244800E-01
Stage1-vs-Stage4
1.772200E-01
Stage2-vs-Stage3
2.080800E-01
Stage2-vs-Stage4
9.414300E-02
Stage3-vs-Stage4
1.180630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.795800E-01
Normal-vs-AfricanAmerican
5.945000E-01
Normal-vs-Asian
8.007200E-01
Caucasian-vs-AfricanAmerican
9.868000E-01
Caucasian-vs-Asian
6.328000E-01
AfricanAmerican-vs-Asian
7.493000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.659000E-01
Normal-vs-Female
5.650400E-01
Male-vs-Female
7.922000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.526200E-01
Normal-vs-Age(41-60Yrs)
3.016800E-01
Normal-vs-Age(61-80Yrs)
7.144200E-01
Normal-vs-Age(81-100Yrs)
6.831600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.694200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.537400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.547000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.770140E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.033800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.098800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.987600E-01
Normal-vs-Daily Drinker
7.865800E-01
Normal-vs-Weekly Drinker
3.863000E-01
Normal-vs-Occasional Drinker
6.242600E-01
Normal-vs-Social Drinker
3.580000E-01
Non Drinker-vs-Daily Drinker
8.964600E-01
Non Drinker-vs-Weekly Drinker
1.872990E-01
Non Drinker-vs-Occasional Drinker
4.506200E-01
Non Drinker-vs-Social Drinker
1.535020E-01
Daily Drinker-vs-Weekly Drinker
3.028800E-01
Daily Drinker-vs-Occasional Drinker
5.810800E-01
Daily Drinker-vs-Social Drinker
2.619600E-01
Weekly Drinker-vs-Occasional Drinker
6.924600E-01
Weekly Drinker-vs-Social Drinker
9.505600E-01
Occasional Drinker-vs-Social Drinker
6.439400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.501000E-01
Normal-vs-Grade 2
7.480800E-01
Normal-vs-Grade 3
2.802800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.275270E-03
Grade 1-vs-Grade 3
3.418300E-04
Grade 1-vs-Grade 4
9.501000E-01
Grade 2-vs-Grade 3
2.556800E-01
Grade 2-vs-Grade 4
7.480800E-01
Grade 3-vs-Grade 4
2.802800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.550400E-01
Normal-vs-NonDiabetic
6.064400E-01
Diabetic-vs-NonDiabetic
8.797600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.350200E-01
Normal-vs-NoPancreatitis
6.064000E-01
Pancreatitis-vs-NoPancreatitis
5.151400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.089000E-01
Normal-vs-N1
4.289800E-01
N0-vs-N1
9.992200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.815600E-01
Normal-vs-TP53-NonMutant
8.223600E-01
TP53-Mutant-vs-TP53-NonMutant
2.019700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
